About XXII
22nd Century Group, Inc. (Nasdaq: XXII) is an agricultural biotechnology company dedicated to enhancing health and wellness through plant science. They focus on controlling nicotine biosynthesis in tobacco plants, aiming to reduce the harm associated with smoking.
Min project size
50,000+
Hourly rate
50 / hr
Employees
360
Locations
France
Year founded
Founded 2015
Share Your Experience
Help others by sharing your experience with this company
No reviews yet
Be the first to review this company!